≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Kela reimbursement Agammaglobulinemia (D80-84)

DOID EFO Endpoint Browser PheWeb

D3_KELA_IMMUDEF

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • KELA reimbursements: KELA codes — 120

1 out of 7 registries used, show all original rules.

300

4. Check minimum number of events

None

300

5. Include endpoints

None

300

6. Filter based on genotype QC (FinnGen only)

300

Control definitions (FinnGen only)

Control exclude
D3_IMMUNEMECHANISM

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 979 566 411
Only index persons 863 510 353
Unadjusted period prevalence (%)
Whole population 0.01 0.02 0.01
Only index persons 0.02 0.02 0.01
Median age at first event (years)
Whole population 42.67 45.86 38.29
Only index persons 41.96 46.26 35.76

-FinnGen-

Key figures

All Female Male
Number of individuals 300 193 107
Unadjusted period prevalence (%) 0.06 0.07 0.05
Median age at first event (years) 44.08 45.84 40.90

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
258
Matched controls
2578
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
120
Kela drug reimbursment
Hypogammaglobulinaemia
+∞
323.0
258
*
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
+∞
294.4
223
*
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
+∞
188.4
157
*
ZX120
NOMESCO Finland
Intravenous
26.7
93.4
139
108
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
+∞
91.2
82
*
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
+∞
88.8
80
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
49.4
80.5
97
31
6BA02
NOMESCO Finland
NA
324.5
73.5
71
*
J01MA12
ATC
levofloxacin; systemic
13.1
68.1
143
224
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
+∞
67.7
62
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
29.7
64.2
88
44
WW200
NOMESCO Finland
Immunization
47.5
62.0
75
22
J01MA14
ATC
moxifloxacin; systemic
18.5
61.1
100
85
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
+∞
59.7
55
*
D83.0
ICD-10 Finland
Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
+∞
58.6
54
*
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
15.5
57.5
102
104
J18.9
ICD-10 Finland
Pneumonia, unspecified
10.0
56.3
138
266
J47
ICD-10 Finland
Bronchiectasis
108.5
55.6
59
7
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
39.6
54.1
68
23
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
43.8
53.7
66
20
D83.9
ICD-10 Finland
Common variable immunodeficiency, unspecified
+∞
51.8
48
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
7.9
50.6
189
664
TPH04
NOMESCO Finland
Cathetrisation of vein
8.6
50.0
135
292
TDM10
NOMESCO Finland
Puncture of maxillary antrum
22.6
49.9
74
45
C01CA24
ATC
epinephrine; parenteral
15.3
48.6
85
80
H02AB06
ATC
prednisolone; systemic
7.3
45.4
198
803
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
13.8
43.3
79
80
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
8.8
42.8
106
190
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
6.6
40.9
138
382
J01.0
ICD-10 Finland
Acute maxillary sinusitis
6.7
40.4
133
355
Z01.8
ICD-10 Finland
Other specified special examinations
6.4
37.0
121
312
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
12.4
36.0
68
72
R50.9
ICD-10 Finland
Fever, unspecified
7.2
34.2
95
193
UDH02
NOMESCO Finland
Rhinopharyngoscopy
11.1
32.5
65
76
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
12.7
32.4
60
60
UGC12
NOMESCO Finland
Flexible bronchoscopy
13.5
32.3
58
54
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
6.2
31.8
101
242
TGC00
NOMESCO Finland
Bronchial lavation
36.1
31.4
40
13
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
17.8
29.1
46
31
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
4.8
28.3
197
1043
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.7
28.2
126
432
SPAT1262
SPAT
Handing over of treatment supplies
5.7
27.2
90
220
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
10.8
26.7
53
60
J01FA06
ATC
roxithromycin; oral
4.3
26.6
160
715
J01MA02
ATC
ciprofloxacin; systemic
4.3
26.0
136
530
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
275.6
25.1
25
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
8.4
25.0
58
86
J45.1
ICD-10 Finland
Nonallergic asthma
8.4
25.0
58
86
Z3231
NOMESCO Finland
Registered nurse
4.3
24.2
119
432
J01FA10
ATC
azithromycin; systemic
4.5
23.8
211
1282
J01FA15
ATC
telithromycin; oral
6.0
22.9
69
147
R03BB04
ATC
tiotropium bromide; inhalant
8.7
22.7
51
71
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
8.7
22.4
50
69
D83.8
ICD-10 Finland
Other common variable immunodeficiencies
+∞
22.2
21
*
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
88.0
22.1
24
*
D80.2
ICD-10 Finland
Selective deficiency of immunoglobulin A [IgA]
239.5
21.9
22
*
R01AD09
ATC
mometasone; nasal
3.7
21.8
171
897
J45.9
ICD-10 Finland
Asthma, unspecified
4.6
21.4
88
263
J01FF01
ATC
clindamycin; systemic
3.9
21.2
114
435
J45.0
ICD-10 Finland
Predominantly allergic asthma
6.1
21.1
62
127
GD1AD
NOMESCO Finland
Thorax CT examination
13.3
21.0
37
32
J01AA02
ATC
doxycycline; systemic
5.1
20.8
229
1573
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
6.6
20.8
57
106
R03AC02
ATC
salbutamol; inhalant
3.7
20.7
185
1055
H02AB07
ATC
prednisone; oral
5.0
20.5
74
192
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
8.2
20.4
47
68
A07AA02
ATC
nystatin; oral
9.1
19.5
42
54
R03AK06
ATC
salmeterol and fluticasone; inhalant
5.3
19.5
65
154
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
4.1
19.2
90
300
B29
ICPC
Lymph/immune mech sympt/complt other
75.7
19.0
21
*
ZXA10
NOMESCO Finland
Bilateral
4.3
18.9
82
254
XW000
NOMESCO Finland
Bone marrow biopsy
11.1
18.9
36
37
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
16.0
18.6
30
21
UJF30
NOMESCO Finland
Ileoscopy through colon
6.0
18.4
54
109
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
9.2
18.3
39
49
A41.9
ICD-10 Finland
Sepsis, unspecified
16.2
18.1
29
20
TAB00
NOMESCO Finland
Lumbar puncture
9.4
17.7
37
45
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
3.2
17.6
172
989
R03DC03
ATC
montelukast; oral
3.9
17.6
85
288
J01FA09
ATC
clarithromycin; systemic
3.3
17.5
125
575
Z2221
NOMESCO Finland
Medical doctor
3.4
17.4
110
461
JN4BD
NOMESCO Finland
Extensive body CT
5.3
17.3
56
127
H04.10
ICD-10 Finland
Dry eye syndrome
5.6
17.3
53
113
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
53.9
17.2
20
*
J05AB01
ATC
aciclovir; systemic
3.8
17.1
85
294
J46
ICD-10 Finland
Status asthmaticus
14.8
16.9
28
21
J06BA02
ATC
immunoglobulins, normal human, for intravascular adm.; systemic
+∞
16.9
16
*
M36.8*D80.1
ICD-10 Finland
Systemic disorders of connective tissue in hypogammaglobulinaemia
+∞
16.9
16
*
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
96.4
16.8
18
*
J32.4
ICD-10 Finland
Chronic pansinusitis
15.9
16.2
26
18
R03BA02
ATC
budesonide; inhalant
3.8
16.2
78
261
Z3226
NOMESCO Finland
Physiotherapist
3.7
16.0
82
287
D84.18
ICD-10 Finland
Other specified defect in the complement system
+∞
15.8
15
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.5
15.8
60
161
WZC30
NOMESCO Finland
Teaching
4.3
15.7
64
184
J05AB11
ATC
valaciclovir; oral
4.3
15.7
64
184
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
9.5
15.5
32
38
R01AD08
ATC
fluticasone; nasal
3.1
15.4
115
534
J02AC01
ATC
fluconazole; systemic
3.0
15.4
141
747
ZXE10
NOMESCO Finland
More than one and less than three hours
3.0
15.2
122
593
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
5.7
15.1
45
92
WX408
NOMESCO Finland
General anesthesy, balanced
3.1
14.8
105
465
XQ800
NOMESCO Finland
Prick test
5.4
14.8
46
99
R03BB01
ATC
ipratropium bromide; inhalant
13.7
14.7
25
20
D80.6
ICD-10 Finland
Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia
+∞
14.7
14
*
XF400
NOMESCO Finland
ECG with 12 standard connections
4.0
14.7
66
206
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
7.8
14.7
34
49
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
38.5
14.6
18
5
UJF32
NOMESCO Finland
Coloscopy
3.4
14.6
83
314
ZX110
NOMESCO Finland
Intracutaneous
158.6
14.6
15
*
XG410
NOMESCO Finland
Flow-volume spirometry
8.1
14.6
33
46
R05
ICD-10 Finland
Cough
3.5
14.5
77
276
C03CA01
ATC
furosemide; systemic
3.8
14.3
67
217
N03AX16
ATC
pregabalin; oral
3.3
14.1
84
328
B28
ICPC
Limited function/disability (B)
56.6
14.0
16
*
H02AB09
ATC
hydrocortisone; systemic
9.2
14.0
29
35
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
79.5
13.7
15
*
ZXE00
NOMESCO Finland
One hour or less
2.8
13.6
133
715
L03AA02
ATC
filgrastim; parenteral
11.4
13.6
25
24
J31.0
ICD-10 Finland
Chronic rhinitis
5.5
13.6
41
85
ZXE20
NOMESCO Finland
More than three and less than five hours
4.1
13.6
57
167
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
22.7
13.5
19
9
J01DB01
ATC
cefalexin; oral
4.2
13.4
235
1829
ZX121
NOMESCO Finland
Central venous catheter
42.5
13.3
16
*
A01AB09
ATC
miconazole; local oral
5.5
13.2
40
83
N02AX02
ATC
tramadol; systemic, rectal
2.7
13.1
126
667
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.4
13.1
35
62
ZX108
NOMESCO Finland
Inhalation
24.0
13.1
18
8
R03BA08
ATC
ciclesonide; inhalant
4.5
13.0
48
124
EP1AE
NOMESCO Finland
Neck ultrasound examination
6.2
12.8
35
64
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
4.0
12.7
54
159
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
33.9
12.7
16
5
GD1CG
NOMESCO Finland
Extensive examination of lungs and pleura with high intensity magnet
73.6
12.7
14
*
R03DA04
ATC
theophylline; systemic, rectal
8.7
12.7
27
34
R4110
NOMESCO Finland
Physiotherapy
2.9
12.6
95
430
D84.9
ICD-10 Finland
Immunodeficiency, unspecified
+∞
12.6
12
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.7
12.5
114
577
R01AD05
ATC
budesonide; nasal
4.7
12.5
44
108
M05BA04
ATC
alendronic acid; oral
6.1
12.3
34
63
R03AC12
ATC
salmeterol; inhalant
7.7
12.2
28
40
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.8
12.2
99
468
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
14.3
12.2
20
15
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
3.9
12.1
52
155
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
7.5
12.0
28
41
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
8.4
12.0
26
34
A02BC03
ATC
lansoprazole; oral
2.9
11.9
91
412
N02AA05
ATC
oxycodone; systemic
4.0
11.7
49
142
J45.8
ICD-10 Finland
Mixed asthma
9.0
11.6
24
29
J01DA06
ATC
[U] cefuroxime; systemic
3.4
11.5
61
213
Z31.5
ICD-10 Finland
Genetic counselling
5.1
11.3
36
79
GD1DG
NOMESCO Finland
Extremely extensive MRI examination of pleura with high field magnet
45.4
11.0
13
*
P01AB01
ATC
metronidazole; oral, rectal
2.5
11.0
123
689
R06AE07
ATC
cetirizine; oral
2.5
11.0
146
893
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
18.8
10.9
16
9
ZXA00
NOMESCO Finland
Right side
2.8
10.8
85
389
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.5
10.7
113
609
J01DA01
ATC
[U] cefalexin; systemic
2.5
10.6
180
1241
D83.1
ICD-10 Finland
Common variable immunodeficiency with predominant immunoregulatory T-cell disorders
+∞
10.5
10
*
SPAT1255
SPAT
Intravenous administration of medicine
5.5
10.5
31
63
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
19.8
10.4
15
8
H02AB04
ATC
methylprednisolone; systemic
3.3
10.3
56
199
ZXA05
NOMESCO Finland
Left side
2.8
10.3
78
346
C10AC01
ATC
colestyramine; oral
13.9
10.3
17
13
R03BA05
ATC
fluticasone; inhalant
2.9
10.2
69
284
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
8.2
10.1
22
29
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
41.8
10.1
12
*
R06.0
ICD-10 Finland
Dyspnoea
2.8
10.0
74
323
Z01.1
ICD-10 Finland
Examination of ears and hearing
3.5
9.9
49
163
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
21.0
9.9
14
7
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
14.1
9.8
16
12
ZXD10
NOMESCO Finland
Scheduled procedure
2.4
9.8
116
657
XA800
NOMESCO Finland
Neuropsychological investigation
5.2
9.7
30
64
ZXD05
NOMESCO Finland
Urgent procedure
2.5
9.7
99
517
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
6.0
9.7
26
47
UDQ12
NOMESCO Finland
Flexible laryngoscopy
5.7
9.5
27
52
WX882
NOMESCO Finland
High dependency care
8.6
9.5
20
25
R03BA01
ATC
beclometasone; inhalant
3.1
9.5
56
210
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.3
9.5
35
90
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
31.3
9.5
12
*
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
11.3
9.4
17
16
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
10.1
9.4
18
19
Z2446
NOMESCO Finland
Social worker
4.1
9.3
36
97
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
14.4
9.3
15
11
A46
ICD-10 Finland
Erysipelas
3.7
9.3
42
130
A03FA01
ATC
metoclopramide; systemic, rectal
2.7
9.2
72
322
R03AC13
ATC
formoterol; inhalant
5.2
9.2
28
59
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.0
9.2
56
217
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
38.1
9.1
11
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.9
9.1
58
231
WW500
NOMESCO Finland
Blood transfusion
7.3
9.0
21
31
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
6.8
9.0
22
35
50301
ICD-8 Finland
Chronic sinusitis, Maxillaris NUD
25.1
9.0
12
5
A07AA09
ATC
vancomycin; oral
25.1
9.0
12
5
J01.4
ICD-10 Finland
Acute pansinusitis
25.1
9.0
12
5
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.7
8.9
68
299
ZX114
NOMESCO Finland
Intramuscular
10.0
8.9
17
18
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.8
8.8
60
249
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
8.7
8.7
18
22
A02BC02
ATC
pantoprazole; systemic
2.2
8.7
167
1162
M04AA01
ATC
allopurinol; systemic
3.9
8.7
36
103
E0000UV
ATC
NA
2.2
8.7
121
728
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.5
8.6
41
132
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.2
8.6
48
174
A02BC01
ATC
omeprazole; systemic
2.5
8.6
76
366
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
28.6
8.6
11
*
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
20.9
8.5
12
6
ZX112
NOMESCO Finland
Subcutaneous
8.3
8.5
18
23
R01AD12
ATC
fluticasone furoate; nasal
2.3
8.5
104
588
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.8
8.5
61
260
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.3
8.4
105
598
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.5
8.4
40
129
D84.19
ICD-10 Finland
Unspecified defect in the complement system
+∞
8.4
8
*
D86.0
ICD-10 Finland
Sarcoidosis of lung
+∞
8.4
8
*
D86.2
ICD-10 Finland
Sarcoidosis of lung with sarcoidosis of lymph nodes
+∞
8.4
8
*
2790B
ICD-9 Finland
Disorders involving the immune mechanism, Deficiency of humoral immunity[DEFICIENTIA IMMUNOGLOBULINI A]
+∞
8.4
8
*
D81.0
ICD-10 Finland
Severe combined immunodeficiency [SCID] with reticular dysgenesis
+∞
8.4
8
*
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
+∞
8.4
8
*
WX002
NOMESCO Finland
Sedation and analgesia
2.7
8.3
60
256
R01AD01
ATC
beclometasone; nasal
2.8
8.3
55
224
H65.2
ICD-10 Finland
Chronic serous otitis media
15.1
8.3
13
9
A41.8
ICD-10 Finland
Other specified sepsis
15.1
8.3
13
9
B03BA03
ATC
hydroxocobalamin; parenteral
7.2
8.2
19
28
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
5.9
8.2
22
40
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
10.5
8.1
15
15
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.7
8.1
35
104
R03AC03
ATC
terbutaline; inhalant
2.8
8.1
54
220
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
34.5
8.1
10
*
R03AK11
ATC
formoterol and fluticasone; inhalant
7.7
8.1
18
25
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.7
8.1
35
105
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
5.8
8.0
22
41
R03AK07
ATC
formoterol and budesonide; inhalant
2.5
8.0
70
331
R01BA52
ATC
pseudoephedrine, combinations; oral
2.2
8.0
98
552
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.8
8.0
34
100
N02BE01
ATC
paracetamol; systemic, rectal
2.7
8.0
223
1816
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
3.4
7.9
39
130
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.2
7.9
43
152
H66.0
ICD-10 Finland
Acute suppurative otitis media
3.5
7.8
37
119
R1250
NOMESCO Finland
Evaluation of functional capability
7.8
7.8
17
23
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
15.6
7.8
12
8
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
2.4
7.8
77
390
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.4
7.7
71
347
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
19.1
7.7
11
6
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
19.1
7.7
11
6
UDM02
NOMESCO Finland
Sinoscopy
9.3
7.7
15
17
212
Kela drug reimbursment
Gout
25.9
7.6
10
*
J96.0
ICD-10 Finland
Acute respiratory failure
25.9
7.6
10
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
25.9
7.6
10
*
J01DA08
ATC
[U] cefaclor; oral
2.9
7.6
47
182
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
7.5
7.6
17
24
A06AD11
ATC
lactulose; oral
3.4
7.6
37
122
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
3.2
7.6
39
134
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
5.9
7.5
20
36
ZYC01
NOMESCO Finland
Remote contact by phone
5.2
7.5
22
45
K90.9
ICD-10 Finland
Intestinal malabsorption, unspecified
82.4
7.5
8
*
JN4AD
NOMESCO Finland
Body CT examination
4.1
7.5
28
74
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.6
7.4
18
29
2790C
ICD-9 Finland
Disorders involving the immune mechanism, Deficiency of humoral immunity[DEFICIENTIA IMMUNOGLOBULINI ALIA]
+∞
7.3
7
*
27510
ICD-8 Finland
Plasma protein abnormalities, Hypogammaglobulinaemia
+∞
7.3
7
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.8
7.3
30
86
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.6
7.3
32
97
J01CA04
ATC
amoxicillin; systemic
2.6
7.3
224
1857
RD210
NOMESCO Finland
NA
8.3
7.2
15
19
5BA08
NOMESCO Finland
NA
31.0
7.2
9
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
20.7
7.2
10
5
J15.8
ICD-10 Finland
Other bacterial pneumonia
20.7
7.2
10
5
D07AB08
ATC
desonide; topical
3.0
7.2
41
151
K29.3
ICD-10 Finland
Chronic superficial gastritis
9.2
7.1
14
16
D07AB02
ATC
hydrocortisone butyrate; topical
2.2
7.1
84
461
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
6.7
7.1
17
27
ZXE30
NOMESCO Finland
More than five and less than seven hours
5.1
7.0
21
44
R06AE09
ATC
levocetirizine; oral
2.6
7.0
55
245
WX892
NOMESCO Finland
Monitored bed care
3.6
7.0
31
95
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
3.9
7.0
28
79
A28
ICPC
Limited function/disability NOS
3.4
6.9
33
107
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
11.4
6.9
12
11
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
9.7
6.9
13
14
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
9.7
6.9
13
14
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
9.7
6.9
13
14
L04AA06
ATC
mycophenolic acid; systemic
9.7
6.9
13
14
A04AA01
ATC
ondansetron; systemic, rectal
3.9
6.8
27
75
R81
ICPC
Pneumonia
7.5
6.8
15
21
N06AX21
ATC
duloxetine; oral
2.9
6.8
42
162
N03AX11
ATC
topiramate; oral
5.8
6.7
18
33
J05AH02
ATC
oseltamivir; oral
23.2
6.7
9
*
B99
ICPC
Blood/lymph/spleen disease other
23.2
6.7
9
*
A87.9
ICD-10 Finland
Viral meningitis, unspecified
23.2
6.7
9
*
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
8.2
6.7
14
18
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
2.2
6.7
80
441
1XC02
NOMESCO Finland
NA
12.7
6.6
11
9
N05BA01
ATC
diazepam; systemic, rectal
2.7
6.6
45
186
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.5
6.6
16
26
Z50.1
ICD-10 Finland
Other physical therapy
4.7
6.5
21
48
XF404
NOMESCO Finland
Ambulatory ECG
3.6
6.5
28
84
Z71.8
ICD-10 Finland
Other specified counselling
2.2
6.5
73
389
ZY010
NOMESCO Finland
Hospital outpatient
3.7
6.5
27
79
J32.8
ICD-10 Finland
Other chronic sinusitis
71.5
6.5
7
*
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
71.5
6.5
7
*
D73.1
ICD-10 Finland
Hypersplenism
71.5
6.5
7
*
R51.80
ICD-10 Finland
Headache
2.6
6.4
49
214
127
Kela drug reimbursment
Transplant complication
8.5
6.4
13
16
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
7.3
6.3
14
20
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
18.6
6.3
9
5
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
18.6
6.3
9
5
G40.9
ICD-10 Finland
Epilepsy, unspecified
5.6
6.3
17
32
D84.1
ICD-10 Finland
Defects in the complement system
+∞
6.3
6
*
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
+∞
6.3
6
*
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
+∞
6.3
6
*
D81.1
ICD-10 Finland
Severe combined immunodeficiency [SCID] with low T- and B-cell numbers
+∞
6.3
6
*
3XA02
NOMESCO Finland
NA
+∞
6.3
6
*
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
+∞
6.3
6
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
27.4
6.3
8
*
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
3.2
6.3
32
110
A07EA06
ATC
budesonide; oral, local oral
4.9
6.2
19
41
ZXD20
NOMESCO Finland
Day surgery
2.6
6.2
46
199
N03AX12
ATC
gabapentin; oral
2.6
6.2
46
199
R03AK08
ATC
formoterol and beclometasone; inhalant
4.6
6.2
20
46
J01DC02
ATC
cefuroxime; systemic
3.6
6.2
27
82
L04AX01
ATC
azathioprine; systemic
4.4
6.2
21
51
D70.89
ICD-10 Finland
Neutropenic splenomegaly
12.9
6.1
10
8
PJA10
NOMESCO Finland
Exploration of lymph nodes
12.9
6.1
10
8
TQW99
NOMESCO Finland
Other minor procedure on skin
5.4
6.1
17
33
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.0
6.1
35
129
A02BC05
ATC
esomeprazole; systemic
2.0
6.1
109
701
SAA04
NOMESCO Finland
Special inverstigation of mouth
3.8
6.1
24
67
N03AX09
ATC
lamotrigine; oral
4.1
6.1
22
57

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3028026) IgM [Mass/volume] in Serum or Plasma
235
157
65.47
302.47
5.5
1.6
g/l
1.0
1.6
1.17
203
149
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
137
11
228.38
283.06
3.4
1.4
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
145
22
126.63
278.79
3.4
1.4
e9/l
1.2
1.2
—
113
5
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
104
19
83.25
190.67
3.6
1.3
e6/l
523.7
824.9
0.75
87
13
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
102
19
80.82
186.18
3.6
1.3
e9/l
0.2
0.2
0.02
87
13
(4062490)
88
19
65.13
155.03
2.6
1.4
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
85
19
62.03
148.43
2.2
1.4
g/l
4.4
7.6
2.92
66
12
(3028192) IgG subclass 2 [Mass/volume] in Serum
85
19
62.03
148.43
2.2
1.4
g/l
1.9
3.1
0.90
64
11
(3024139) IgG subclass 3 [Mass/volume] in Serum
85
19
62.03
148.43
2.2
1.4
g/l
0.2
0.4
0.93
65
12
(3024980) IgG subclass 4 [Mass/volume] in Serum
89
36
34.73
131.48
2.1
1.6
g/l
0.2
0.7
3.40
65
29
(3023419) Bacteria identified in Sputum by Culture
81
25
44.01
130.09
4.5
2.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
71
22
41.97
113.37
3.0
1.5
e6/l
800.4
770.7
0.06
18
11
(3005322) IgE [Units/volume] in Serum or Plasma
140
178
13.87
113.28
2.1
1.2
u/ml
80.8
258.2
0.71
94
164
(3007164) IgA [Mass/volume] in Serum or Plasma
238
589
15.71
113.16
5.7
1.4
g/l
1.2
2.3
13.40
165
376
(3010503) CD19 cells [#/volume] in Blood
62
14
55.56
106.90
2.8
1.4
e9/l
0.5
0.2
0.42
62
14
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
78
46
22.56
97.99
6.3
5.3
iu/ml
676.7
213.6
—
13
7
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
74
55
17.53
82.27
3.6
2.8
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
243
803
11.66
81.30
22.1
5.9
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
69
55
15.99
73.46
2.8
1.8
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
83
89
12.51
73.41
3.4
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
69
56
15.70
72.68
2.9
1.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
67
53
15.99
71.57
1.8
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
99
145
9.70
69.07
3.1
1.6
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
48
20
28.38
68.70
3.5
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
48
21
27.02
67.45
3.5
1.1
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
80
94
11.24
65.98
2.0
1.4
g/l
1.2
1.2
0.49
73
89
(3023368) Bacteria identified in Blood by Culture
172
483
7.00
64.06
9.9
4.2
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
265
1141
12.34
62.15
26.1
6.0
%
0.7
0.7
0.00
265
1067
(3019069) Monocytes/100 leukocytes in Blood
267
1173
12.60
60.84
27.0
6.3
%
9.0
8.3
3.20
267
1107
(3006504) Eosinophils/100 leukocytes in Blood
266
1170
12.24
60.31
26.5
6.0
%
2.6
2.8
0.94
266
1096
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
133
310
6.91
59.59
3.9
1.9
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
266
1202
11.70
57.52
25.3
5.9
%
57.9
56.2
1.43
266
1136
(3002030) Lymphocytes/100 leukocytes in Blood
267
1215
11.89
57.19
26.8
6.0
%
28.3
29.5
1.01
267
1146
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
108
213
7.36
56.92
3.3
1.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
53
41
15.49
56.89
2.3
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
41
21
22.46
53.79
5.2
2.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
94
175
7.37
51.98
9.0
4.8
%
0.6
0.5
0.18
32
42
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
103
216
6.74
50.54
3.7
1.7
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
38
20
21.61
49.16
5.4
2.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
48
40
14.10
49.13
2.9
2.0
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
96
195
6.77
48.48
10.0
5.0
%
0.9
0.9
0.02
35
67
(3000494) Fungus identified in Specimen by Culture
115
281
6.01
47.73
2.5
1.5
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
44
0
+∞
47.14
1.6
0.0
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
33
14
26.36
46.45
2.2
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
119
307
5.77
46.33
3.4
2.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
35
20
19.68
43.52
1.8
1.9
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
88
181
6.46
43.51
10.5
5.2
%
0.2
0.1
0.42
35
57
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
39
0
+∞
41.64
2.1
0.0
mg/l
1.0
—
—
27
0
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
39
0
+∞
41.64
2.1
0.0
mg/l
0.7
—
—
24
0
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
39
0
+∞
41.64
2.1
0.0
mg/l
0.9
—
—
27
0
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
39
0
+∞
41.64
2.1
0.0
mg/l
0.7
—
—
25
0
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
39
0
+∞
41.64
2.1
0.0
mg/l
1.2
—
—
23
0
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
39
0
+∞
41.64
2.1
0.0
mg/l
0.4
—
—
25
0
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
39
0
+∞
41.64
2.1
0.0
mg/l
1.1
—
—
24
0
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
39
0
+∞
41.64
2.1
0.0
mg/l
1.9
—
—
22
0
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
39
0
+∞
41.64
2.1
0.0
mg/l
3.2
—
—
25
0
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
39
0
+∞
41.64
2.1
0.0
mg/l
2.9
—
—
24
0
(3000492) Spirometry study
106
269
5.55
41.54
3.9
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
108
280
5.46
41.27
3.2
2.5
%
21.6
23.9
0.69
96
240
(3007853) Bacteria identified in Skin by Aerobe culture
105
267
5.51
41.00
2.5
1.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
83
174
6.21
40.00
11.0
5.2
%
0.0
0.0
0.07
30
48
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
39
33
13.43
39.32
2.8
1.6
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
31
17
20.22
39.17
1.1
7.7
u/ml
—
42.2
—
0
6
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
42
41
11.75
38.66
2.2
1.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
73
140
6.57
38.45
5.5
2.9
e9/l
82.5
77.1
0.34
53
104
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
38
32
13.45
38.40
2.2
1.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
46
52
10.27
38.21
3.5
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
163
623
4.54
37.59
19.9
6.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
34
25
15.21
37.11
2.6
1.7
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
41
41
11.42
37.09
1.7
2.1
g/l
119.3
132.4
—
8
29
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
38
35
12.29
36.27
2.5
1.6
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
34
0
+∞
36.18
1.9
0.0
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
85
202
5.48
35.41
6.3
3.2
%
2.0
1.8
0.56
80
186
(44790049)
33
25
14.71
35.38
2.6
1.7
—
—
—
0
0
(44790048)
33
25
14.71
35.38
2.6
1.7
—
—
—
0
0
(44806118)
33
25
14.71
35.38
2.6
1.7
—
—
—
0
0
(44790047)
33
25
14.71
35.38
2.6
1.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
63
113
6.79
35.30
3.4
2.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
222
1110
4.85
34.54
30.9
8.7
e9/l
0.0
0.0
0.58
213
899
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
285
1807
12.54
31.70
23.8
7.3
u/l
90.0
77.8
5.18
285
1705
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
40
48
9.46
31.61
2.0
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
285
1822
12.28
30.97
16.8
3.9
mm/h
12.2
9.7
2.64
280
1692
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
38
44
9.74
30.83
9.0
3.8
%
55.4
56.8
0.19
38
44
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
208
1060
4.14
29.79
16.3
7.1
mmol/l
1.2
1.2
0.21
181
904
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
31
29
11.81
29.13
2.9
1.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
32
32
11.07
28.77
1.8
1.8
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
84
232
4.64
28.74
3.2
1.9
nmol/l
327.1
364.3
0.94
77
216
(40760892) CBC W Ordered Manual Differential panel - Blood
148
613
3.79
28.68
15.0
4.8
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
109
368
4.08
28.47
1.9
1.4
titre
556.8
492.5
0.19
25
80
(3048689) Calprotectin [Mass/mass] in Stool
106
351
4.12
28.45
2.4
2.6
ug/g
189.9
109.2
0.98
92
284
(3018418) pH of Serum or Plasma
151
644
3.71
27.79
6.5
4.0
ph
7.4
7.4
0.58
37
109
(3025468) Yersinia sp identified in Specimen by Organism specific culture
30
30
11.00
26.93
4.6
1.5
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
191
964
3.70
26.72
18.0
6.4
mmol/l
1.2
1.2
2.14
183
882
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
29
28
11.36
26.64
1.4
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
25
19
14.26
26.57
2.4
2.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
25
19
14.26
26.57
2.4
2.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
25
19
14.26
26.57
2.4
2.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
63
146
5.20
26.53
1.9
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
30
31
10.64
26.32
4.6
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
30
31
10.64
26.32
4.6
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
30
31
10.64
26.32
4.6
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
30
31
10.64
26.32
4.6
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
30
31
10.64
26.32
4.6
1.5
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
29
5
63.89
25.49
1.1
1.0
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
43
72
6.80
25.44
2.0
2.5
g/l
1.3
1.4
0.29
33
63
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
24
19
13.64
24.88
4.6
3.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
28
5
61.46
24.48
1.1
1.0
%
96.2
83.2
—
28
5
(3052851) Hemolysis interference index of Serum or Plasma
41
69
6.72
24.10
2.6
3.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
20
12
17.79
23.94
2.5
2.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
20
12
17.79
23.94
2.5
2.3
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
20
12
17.79
23.94
2.5
2.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
20
12
17.79
23.94
2.5
2.3
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
37
58
7.14
23.22
1.5
1.3
u/ml
2.5
0.9
—
8
5
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
160
770
3.31
23.21
6.2
3.1
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
21
15
14.98
23.00
4.1
1.4
umol/l
24.2
30.2
1.01
21
15
(3015171) Extractable nuclear Ab [Units/volume] in Serum
48
100
5.52
22.64
1.6
1.3
u/ml
0.5
3.9
—
8
7
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
30
39
8.44
22.08
1.7
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
30
39
8.44
22.08
1.7
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
27
32
9.17
21.34
1.8
1.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
18
11
17.34
21.28
3.2
1.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
71
6.16
21.16
3.4
2.5
g/l
2.9
3.1
0.55
26
62
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
75
6.00
21.06
3.4
2.4
g/l
7.1
7.4
0.36
27
64
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
75
6.00
21.06
3.4
2.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
75
6.00
21.06
3.4
2.4
g/l
2.8
3.7
3.34
26
61
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
48
107
5.15
20.94
2.3
1.4
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
22
20
11.79
20.89
1.5
1.2
u/l
245.5
89.1
0.36
17
13
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
22
20
11.79
20.89
1.6
1.1
u/ml
0.4
0.1
—
13
7
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
18
12
15.89
20.37
1.8
1.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
36
64
6.26
19.97
1.4
1.5
ug/g
382.0
270.2
2.62
30
41
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
20
17
12.53
19.77
1.1
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
18
13
14.67
19.51
1.8
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
25
9
30.13
19.05
1.5
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
32
53
6.64
18.99
1.7
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
42
91
5.20
18.86
2.2
2.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
129
603
3.00
18.76
5.3
2.9
e6/l
0.3
0.4
0.31
111
444
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
33
58
6.27
18.48
1.6
1.3
u/ml
25.1
49.1
—
10
6
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
30
48
6.83
18.38
2.3
1.9
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
26
36
7.81
18.09
1.5
1.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
106
452
3.08
18.05
5.0
2.4
e6/l
3.9
6.2
1.53
101
392
(36304419) Bacteria [Presence] in Urine
127
599
2.94
18.03
5.2
2.8
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
151
787
2.85
17.70
9.2
6.5
inr
1.0
1.1
2.16
51
250
(3018095) Leukocytes [#/volume] in Urine
153
804
2.84
17.64
6.3
3.5
e6/l
35.8
45.7
0.27
123
548
(3002582) Erythrocytes [#/volume] in Urine
135
667
2.86
17.46
5.6
3.0
e6/l
14.9
36.8
1.45
119
504
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
30
51
6.42
17.34
1.7
1.3
u/ml
91.3
108.4
—
12
8
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
27
41
7.14
17.33
1.4
1.9
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
61
191
3.75
16.99
14.2
4.5
mmol/l
1.8
2.2
0.40
55
145
(3013826) Glucose [Moles/volume] in Serum or Plasma
209
1311
2.96
16.88
13.8
4.8
mmol/l
6.4
6.5
0.26
203
1215
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
22
27
8.71
16.85
1.6
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
36
76
5.25
16.60
1.6
1.3
u/ml
1.4
6.4
—
7
19
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
129
636
2.80
16.57
4.8
2.0
u/l
124.8
255.9
0.69
123
609
(3018677) aPTT in Platelet poor plasma by Coagulation assay
82
317
3.18
16.35
4.1
2.2
s
30.2
29.7
0.33
75
310
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
16
13
12.94
16.15
1.1
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
20
23
9.25
16.07
5.9
3.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
22
29
8.11
15.90
1.6
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
35
76
5.08
15.61
1.6
1.3
u/ml
3.5
3.2
—
5
12
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
18
19
10.01
15.37
3.2
1.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
20
25
8.50
15.07
1.8
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
40
100
4.46
15.06
10.1
9.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
20
8
26.63
14.89
1.5
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
20
8
26.63
14.89
1.5
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
82
333
3.01
14.88
1.9
1.6
nmol/l
1390.6
1137.0
1.45
71
249
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
113
545
2.72
14.85
2.9
1.8
mg/l
1.0
0.9
0.22
98
401
(40768797) Stomach Pathology biopsy report
79
315
3.05
14.80
1.4
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
17
18
9.95
14.46
1.2
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
17
18
9.95
14.46
1.1
1.7
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
16
16
10.51
14.14
1.1
1.2
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
32
70
5.00
14.13
1.3
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
102
479
2.71
14.00
5.2
2.7
ng/l
1066.7
657.2
0.41
92
379
(3026389) Candida sp identified in Specimen by Organism specific culture
17
19
9.42
13.90
2.2
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
99
461
2.71
13.79
2.0
1.6
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
18
22
8.64
13.77
1.3
1.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
232
1625
2.89
13.70
8.0
3.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
33
77
4.69
13.49
1.3
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
100
477
2.64
13.19
2.2
1.4
nmol/l
22.1
22.4
0.07
94
410
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
14
13
11.25
12.95
3.4
1.8
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
23
40
6.14
12.94
1.1
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
115
594
2.52
12.80
2.3
1.9
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
72
4.69
12.74
3.6
2.4
g/l
7.3
10.6
2.88
26
66
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
293
2526
7.85
12.63
53.0
11.5
mg/l
15.9
20.0
2.93
288
1908
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
16
19
8.84
12.48
2.2
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
43
130
3.69
12.46
5.5
2.4
ng/l
207.4
113.5
0.39
38
115
(4035726)
55
195
3.23
12.45
2.2
1.4
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
51
173
3.35
12.40
22.2
11.9
%
94.8
96.2
0.92
44
166
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
14
10.44
12.32
3.4
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
31
74
4.56
12.31
6.5
1.9
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
21
35
6.38
12.30
5.5
5.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
182
1175
2.40
12.08
5.6
3.2
estimate
0.0
0.0
0.00
48
225
(3000991) Gas panel - Venous blood
52
182
3.25
12.00
22.9
9.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
16
20
8.39
11.99
1.0
1.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
17
23
7.78
11.96
1.5
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
113
594
2.45
11.96
4.6
2.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
182
1179
2.38
11.92
6.9
4.4
estimate
0.0
0.0
0.50
50
228
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
31
76
4.43
11.91
1.5
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
17
9
19.93
11.72
2.8
2.8
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
17
9
19.93
11.72
2.8
2.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
17
9
19.93
11.72
2.8
2.8
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
53
191
3.16
11.64
22.0
11.0
kpa
5.0
5.1
0.30
47
181
(3027801) Oxygen [Partial pressure] in Arterial blood
53
191
3.16
11.64
22.0
11.0
kpa
11.1
12.6
1.20
46
182
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
11
0
+∞
11.53
1.5
0.0
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
291
2519
6.17
11.50
48.2
12.5
mmol/l
139.4
139.7
1.27
291
2457
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
27
61
4.77
11.45
1.6
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
35
97
3.95
11.45
25.5
15.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
182
1192
2.34
11.44
5.6
3.2
estimate
0.0
0.0
0.50
50
219
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
67
281
2.78
11.20
5.2
2.7
umol/l
8.4
6.4
0.31
60
249
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
16
22
7.63
11.09
1.2
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
80
371
2.58
10.94
1.9
1.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
52
192
3.07
10.93
22.4
11.1
mmol/l
0.9
1.4
0.35
38
149
(3023103) Potassium [Moles/volume] in Serum or Plasma
291
2531
5.99
10.93
48.4
12.6
mmol/l
3.9
3.9
1.43
291
2461
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
53
198
3.04
10.92
5.1
3.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
88
428
2.49
10.88
2.0
1.6
pmol/l
496.0
18206965.4
0.50
82
368
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
13
14
9.66
10.84
3.6
1.7
—
—
—
0
0
(4027681)
13
14
9.66
10.84
1.4
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
13
14
9.66
10.84
1.7
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
61
249
2.82
10.70
1.6
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
136
807
2.25
10.60
2.6
1.8
pmol/l
89.3
97.7
1.41
89
406
(3015377) Calcium [Moles/volume] in Serum or Plasma
130
759
2.26
10.52
5.3
3.1
mmol/l
2.3
2.4
3.55
124
658
(3014148) Varicella zoster virus Ab [Titer] in Serum
18
30
6.32
10.52
1.6
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
28
70
4.31
10.48
1.6
1.4
iu/ml
0.0
0.0
—
6
13
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
15
8
19.65
10.37
1.2
2.3
iu/ml
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
16
24
6.99
10.28
1.9
1.2
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
14
18
8.11
10.22
3.3
1.7
mg/l
4.3
4.8
0.10
14
18
(3001964) Herpes simplex virus Ag [Presence] in Specimen
11
10
11.38
10.22
1.5
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
82
399
2.45
10.04
5.9
3.1
ng/l
216.2
276.5
0.20
55
261
(3028679) Herpes simplex virus Ab [Presence] in Serum
12
13
9.57
9.93
1.3
1.2
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
12
13
9.57
9.93
1.8
1.5
u/l
1.2
3.7
—
6
7
(3016650) Hepatitis A virus Ab [Presence] in Serum
22
48
4.87
9.70
1.1
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
34
104
3.56
9.64
1.8
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
11
11
10.34
9.60
1.9
2.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
11
11
10.34
9.60
1.9
2.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
97
522
2.27
9.36
4.8
3.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
22
50
4.67
9.24
5.5
4.7
mg/l
23.1
29.9
0.28
16
42
(3034860) Kappa light chains.free [Mass/volume] in Serum
22
50
4.67
9.24
5.5
4.7
mg/l
19.5
159.8
0.63
15
43
(3026493) Urate [Moles/volume] in Serum or Plasma
105
589
2.20
9.12
5.6
2.8
umol/l
320.5
4878.0
1.95
99
515
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
34
108
3.42
9.10
2.6
1.8
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
13
7
19.33
9.01
1.3
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
14
21
6.94
8.97
3.6
1.3
pg
32.1
32.7
0.17
14
21
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
39
138
3.10
8.77
8.1
3.4
mmol/l
0.7
1.7
0.67
29
94
(3044290) Cell count panel - Cerebral spinal fluid
19
40
5.00
8.71
3.8
1.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
108
622
2.15
8.71
6.9
3.4
estimate
0.0
0.0
0.80
50
225
(3009871) Measles virus Ab [Titer] in Serum
10
10
10.31
8.69
2.8
1.7
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
16
29
5.77
8.59
1.5
1.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
12
6
20.75
8.54
1.8
1.5
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
11
13
8.75
8.51
1.2
1.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
10
11
9.37
8.13
1.1
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
10
11
9.37
8.13
1.1
1.1
—
—
—
0
0
(3009343) pH of Capillary blood
39
146
2.92
7.94
8.1
3.3
ph
7.4
7.4
—
7
13
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
39
147
2.90
7.84
8.2
3.3
kpa
4.9
5.1
1.45
34
136
(3008152) Bicarbonate [Moles/volume] in Arterial blood
31
102
3.27
7.84
15.7
11.7
mmol/l
25.5
24.9
0.43
26
94
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
15
28
5.59
7.81
1.8
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
267
2223
2.83
7.79
54.2
14.3
%
14.2
13.5
10.34
267
2195
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
26
77
3.60
7.72
1.9
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
26
77
3.60
7.72
4.3
2.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
16
33
5.07
7.49
3.0
2.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
140
927
1.96
7.43
5.9
3.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
39
153
2.78
7.28
2.8
3.5
pmol/l
4.2
4.6
2.29
34
135
(3021879) Hepatitis B virus core Ab [Presence] in Serum
52
236
2.46
7.25
1.5
1.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
11
16
7.10
7.20
2.6
3.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
13
23
5.86
7.13
1.0
1.1
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
11
8
14.21
6.94
3.2
2.0
ug/l
83.6
60.1
—
11
8
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
11
17
6.68
6.82
1.4
1.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
115
729
1.94
6.80
4.9
2.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
66
345
2.17
6.61
3.8
2.7
e6/l
3.7
2.8
0.38
37
177
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
154
1081
1.87
6.60
7.3
3.9
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
26
86
3.22
6.52
2.9
4.4
g/l
0.3
0.2
0.33
18
46
(3035637) Corticotropin [Mass/volume] in Plasma
14
29
5.01
6.52
1.8
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
67
355
2.14
6.47
3.4
2.6
e6/l
1.1
0.8
0.27
37
186
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
10
7
14.72
6.44
1.1
1.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
12
22
5.64
6.34
1.1
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
11
19
5.97
6.15
3.3
3.8
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
10
8
12.87
6.12
1.1
1.1
miu/ml
1530.6
1868.5
—
10
8
(3008757) Leukocyte morphology finding [Identifier] in Blood
13
27
4.99
6.03
3.5
3.6
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
13
27
4.99
6.03
2.8
1.8
%
90.2
90.9
0.20
13
27
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
79
459
1.98
5.91
1.4
1.3
iu/ml
29.6
34.0
0.16
22
154
(3020891) Body temperature
21
65
3.40
5.84
11.4
5.0
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
14
32
4.54
5.83
3.0
1.9
mmol/l
1.6
1.7
0.31
14
32
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
12
24
5.17
5.79
1.2
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
17
46
3.86
5.73
4.9
2.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
77
450
1.96
5.64
1.4
1.3
u/ml
2.3
9.0
2.08
30
186
(4010399)
37
161
2.48
5.62
1.6
1.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
9
7
13.20
5.61
1.9
1.6
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
12
25
4.96
5.54
1.2
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
12
25
4.96
5.54
5.4
1.8
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
47
232
2.22
5.38
2.9
2.4
u/l
32.1
27.1
0.38
42
195
(3016018) Differential panel - Cerebral spinal fluid
11
22
5.15
5.30
3.4
1.9
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
5
0
+∞
5.22
1.4
0.0
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
8
6
13.65
5.10
1.6
4.3
g/mol
268.0
43.3
—
8
6
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
9
10.26
5.06
1.7
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
104
692
1.77
4.98
5.1
2.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
112
764
1.74
4.90
5.6
3.1
ng/l
113.7
29.9
0.44
71
426
(4034850)
22
79
2.93
4.83
18.3
10.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
133
957
1.70
4.77
2.6
1.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
85
540
1.80
4.72
4.0
2.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
40
196
2.20
4.65
8.6
3.3
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
19
64
3.10
4.64
16.1
11.8
mmol/l
1.4
1.2
0.52
14
54
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
22
81
2.85
4.62
6.5
4.1
%
60.6
53.0
0.63
22
81
(40759836) Histone Ab [Presence] in Serum by Immunoblot
10
21
4.89
4.56
1.3
1.3
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
10
21
4.89
4.56
1.3
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
10
21
4.89
4.56
1.3
1.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
16
49
3.39
4.53
6.3
2.5
mmol/l
2.4
2.5
0.06
11
31
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
264
2324
2.13
4.49
35.2
10.7
ml/min/173m2
91.0
88.4
1.14
250
1891
(3047007) Chlamydophila sp Ab [Presence] in Serum
15
45
3.46
4.38
1.6
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
10
22
4.67
4.33
1.3
1.3
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
10
22
4.67
4.33
1.3
1.3
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
10
22
4.67
4.33
1.3
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
12
31
3.99
4.30
2.8
2.7
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
13
36
3.73
4.25
4.5
2.7
%
15.4
16.8
—
8
16
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
18
63
2.98
4.14
1.3
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
7
7
10.20
4.03
3.4
1.6
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
7
7
10.20
4.03
1.7
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
9
14
6.59
4.01
3.1
4.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
81
532
1.72
3.94
5.0
3.3
kg/l
1.0
1.0
—
6
77
(1761868) Lipid panel - Serum or Plasma
70
1036
0.58
3.94
2.1
2.6
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
11
7.44
3.88
1.8
1.5
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
11
7.44
3.88
1.8
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
11
29
3.90
3.84
1.1
1.4
nmol/l
—
—
—
0
0
(40768443) Skin Pathology biopsy report
21
84
2.61
3.80
1.3
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
7
8
8.92
3.79
1.3
1.5
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
8
12
6.81
3.69
2.8
4.8
—
—
—
0
0
(3010421) pH of Blood
16
56
2.96
3.69
6.4
2.5
ph
7.4
7.4
0.85
16
48
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
9
7.93
3.57
1.4
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
228
1962
1.68
3.57
5.1
3.9
pmol/l
14.8
14.5
1.25
219
1819
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
290
2704
3.17
3.52
31.9
9.4
u/l
30.9
27.3
2.53
290
2625
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
6
6
10.17
3.51
1.8
1.0
—
—
—
0
0
(3044889) 12 lead EKG panel
197
1645
1.58
3.40
5.0
3.2
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
7
10
7.14
3.38
1.7
1.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
11
32
3.53
3.36
1.2
1.0
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
9
19
4.85
3.26
1.2
1.5
u/field
2.4
5.7
—
9
7
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
34
180
2.00
3.26
2.6
2.4
ml/min/173m2
62.8
71.4
0.47
16
75
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
49
2.95
3.23
1.3
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
13
44
3.04
3.17
25.0
3.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
213
1826
1.57
3.14
5.5
3.0
u/l
52.3
43.0
1.80
208
1740
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
88
623
1.58
3.12
1.8
1.6
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
8
16
5.10
3.07
3.3
3.4
%
94.5
100.7
—
8
16
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
8
16
5.10
3.07
4.6
2.3
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
6
8
7.62
3.07
1.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
6
8
7.62
3.07
1.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
6
8
7.62
3.07
1.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
6
8
7.62
3.07
1.0
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
7
12
5.94
3.03
1.3
1.3
—
—
—
0
0
(3024471) HLA-A [Type]
5
5
10.14
2.99
1.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
5
5
10.14
2.99
1.6
1.8
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
5
5
10.14
2.99
1.2
1.0
—
—
—
0
0
(4015189)
5
5
10.14
2.99
2.8
4.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
5
10.14
2.99
2.2
1.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
23
109
2.20
2.93
12.2
3.4
—
—
—
0
0
(3002256) Pathology report gross observation
50
311
1.73
2.92
1.3
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
257
2323
1.74
2.89
5.9
4.6
mu/l
1.9
1.8
0.49
252
2173
(3013139) Helicobacter pylori Ag [Presence] in Stool
29
153
1.99
2.82
1.2
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
10
31
3.30
2.80
1.2
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
12
291
0.39
2.79
1.5
1.7
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
9
23
4.00
2.79
1.4
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
5
6
8.45
2.76
1.0
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
10
6.10
2.71
1.7
4.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
286
2692
2.34
2.59
34.9
10.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
29
158
1.92
2.59
8.1
3.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
222
1956
1.52
2.57
4.7
3.4
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
13
50
2.67
2.56
2.4
1.1
iu/ml
88.3
5.5
—
7
10
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
6
11
5.54
2.55
2.5
1.2
umol/l
4.2
5.9
—
6
11
(3045788) Cell count panel - Pleural fluid
6
11
5.54
2.55
1.7
1.4
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
5
8
6.33
2.38
1.0
1.5
—
—
—
0
0
(3012565) Volume of 24 hour Urine
5
8
6.33
2.38
1.0
3.0
ml
1820.0
1950.0
—
5
8
(3044941) Cell count panel - Synovial fluid
9
28
3.28
2.32
2.2
1.3
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
6
13
4.69
2.28
1.2
1.9
umol/l
8.4
10.0
—
6
13
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
23
122
1.96
2.23
1.1
1.4
miu/ml
336.6
253.9
0.44
12
61
(3002523) Influenza virus A Ag [Presence] in Specimen
13
54
2.47
2.23
1.3
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
13
54
2.47
2.23
1.3
1.0
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
8
24
3.40
2.19
1.0
1.0
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
30
175
1.79
2.19
1.7
1.3
—
34.5
—
0
10
(21494755) Public health laboratory ask at order entry panel
20
363
0.52
2.17
1.3
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
19
3.75
2.16
1.3
1.4
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
12
49
2.51
2.13
1.1
1.2
u/ml
1.4
1.6
—
5
14
(3047189) Immunofixation for 24 hour Urine
5
10
5.06
2.08
1.6
1.9
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
16
76
2.17
2.06
1.8
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
9
204
0.42
2.04
1.1
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
14
63
2.28
2.04
1.2
1.3
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
10
38
2.69
2.03
1.5
1.3
u/l
304.8
13.4
—
10
33
(3014765) Yersinia sp identified in Stool by Organism specific culture
16
77
2.14
2.00
1.8
1.1
—
—
—
0
0
(44813793)
7
21
3.39
1.97
1.0
1.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
20
106
1.95
1.96
1.5
1.3
—
—
—
0
0
(4306422)
11
45
2.50
1.95
1.3
1.2
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
8
27
3.01
1.95
1.3
2.9
nmol/l
7.9
3.0
—
8
27
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
11
4.60
1.95
1.0
1.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
11
4.60
1.95
1.0
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
5
11
4.60
1.95
1.6
1.9
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
16
78
2.11
1.94
1.8
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
44
296
1.57
1.92
1.7
1.7
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
9
34
2.70
1.88
1.1
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
8
28
2.91
1.87
1.5
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
13
59
2.26
1.87
1.5
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
17
3.58
1.84
3.2
3.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
17
3.58
1.84
5.0
2.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
12
4.22
1.83
4.0
2.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
12
4.22
1.83
1.4
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
12
4.22
1.83
1.4
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
5
12
4.22
1.83
1.0
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
10
41
2.49
1.77
1.7
2.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
10
41
2.49
1.77
1.3
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
6
18
3.38
1.75
52.7
4.3
%
10.7
12.9
—
6
18
(3034274) Bile acid [Moles/volume] in Serum --fasting
10
42
2.43
1.69
1.9
1.9
umol/l
8.3
9.0
—
10
29
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
31
2.62
1.67
2.1
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
18
98
1.89
1.65
1.8
1.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
6
20
3.04
1.59
1.2
1.6
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
6
20
3.04
1.59
1.0
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
49
353
1.46
1.57
3.0
2.8
mmol/l
2.5
2.4
0.60
42
301
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
8
33
2.46
1.55
1.3
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
88
705
1.35
1.54
3.3
3.1
mmol/l
7.4
8.1
0.60
79
601
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
32
211
1.58
1.54
1.9
1.2
iu/ml
80.3
148.9
0.75
15
83
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
15
3.37
1.53
2.2
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
29
188
1.60
1.49
2.7
2.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
81
645
1.35
1.47
1.4
1.4
u/ml
0.6
1.7
2.37
15
175
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
11
52
2.16
1.46
1.1
1.2
u/ml
2.4
3.5
—
5
24
(3044927) Protein electrophoresis panel - Urine
5
16
3.16
1.44
1.0
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
22
2.76
1.44
1.2
1.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
15
260
0.55
1.43
16.2
5.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
19
111
1.76
1.43
2.2
2.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
40
2.29
1.41
1.0
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
9
41
2.23
1.38
1.6
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
35
242
1.51
1.38
1.3
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
17
2.97
1.36
1.2
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
74
590
1.34
1.33
4.4
3.2
mg/l
2475.1
434.7
0.85
48
360
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
16
91
1.80
1.31
1.6
1.6
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
19
2.66
1.22
1.0
1.9
g/l
1.0
1.0
—
5
19
(3001019) Free T4 and TSH panel - Serum or Plasma
11
196
0.54
1.17
2.8
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
47
359
1.37
1.11
1.8
1.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
237
2496
0.76
1.10
4.0
4.1
mmol/l
4.6
4.8
1.54
228
2350
(3045414) Leukocytes [Presence] in Urine
15
90
1.70
1.06
3.6
1.6
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
15
91
1.68
1.02
1.4
1.7
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
294
2884
1.97
0.96
65.1
17.1
e9/l
6.4
6.6
0.59
294
2817
(3000963) Hemoglobin [Mass/volume] in Blood
294
2884
1.97
0.96
65.5
17.1
g/l
131.8
137.1
7.75
294
2848
(3026361) Erythrocytes [#/volume] in Blood
294
2883
1.99
0.96
65.1
17.1
e12/l
4.5
4.6
1.22
294
2819
(3024731) MCV [Entitic volume]
294
2882
2.01
0.96
64.7
17.0
fl
89.3
90.3
2.27
294
2847
(3035941) MCH [Entitic mass]
294
2882
2.01
0.96
64.6
17.0
pg
29.6
30.2
4.19
294
2847
(3007461) Platelets [#/volume] in Blood
294
2881
2.02
0.96
65.2
17.1
e9/l
238.3
257.5
3.25
294
2814
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
228
2398
0.79
0.90
3.7
3.6
mmol/l
1.4
1.3
1.72
221
2237
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
48
387
1.29
0.81
2.6
2.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
26
0.00
0.79
0.0
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
73
623
1.23
0.77
4.1
4.0
mg/mmol
23.5
11.0
0.33
47
381
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
22
159
1.41
0.75
2.0
2.5
u/ml
49.0
50.1
0.02
22
152
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
243
2525
0.80
0.74
4.3
4.4
mmol/l
2.8
2.9
1.23
232
2361
(3014051) Protein [Presence] in Urine by Test strip
7
38
1.86
0.74
5.6
1.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
239
2487
0.81
0.74
3.8
4.0
mmol/l
1.4
1.5
1.83
229
2328
(3003694) ABO and Rh group [Type] in Blood
80
693
1.21
0.73
1.6
1.5
—
—
—
0
0
(4281824)
5
25
2.02
0.73
1.6
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
10
157
0.62
0.71
1.4
2.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
7
43
1.64
0.67
2.0
1.4
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
17
120
1.44
0.66
4.8
2.8
e6/l
0.3
0.1
0.75
17
115
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
50
420
1.23
0.62
2.7
2.1
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
21
157
1.36
0.61
1.1
1.2
—
42.9
—
0
7
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
52
1.55
0.60
1.0
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
239
2297
1.20
0.60
54.3
14.6
g/l
331.3
333.5
2.96
239
2285
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
22
285
0.75
0.59
1.7
1.8
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
23
0.00
0.58
0.0
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
30
239
1.28
0.58
2.9
2.1
—
—
—
0
0
(4268621)
6
37
1.63
0.56
2.5
2.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
12
169
0.70
0.53
1.4
2.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
12
169
0.70
0.53
1.4
1.9
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
12
169
0.70
0.53
1.4
2.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
9
63
1.44
0.53
2.6
2.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
12
168
0.70
0.52
1.4
2.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
20
156
1.30
0.46
1.6
1.3
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
10
136
0.73
0.38
2.7
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
76
0.65
0.36
1.6
1.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
43
385
1.14
0.29
1.7
2.0
%
1.7
1.4
0.80
37
353
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
71
0.70
0.26
1.2
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
71
0.70
0.26
1.2
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
71
0.70
0.26
1.2
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
71
0.70
0.26
1.2
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
235
2399
0.91
0.26
4.7
4.0
mmol/l
5.7
5.8
0.23
229
2227
(3009542) Hematocrit [Volume Fraction] of Blood
250
2453
1.11
0.26
48.1
12.2
%
39.7
40.7
2.81
202
1956
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
52
477
1.11
0.24
1.6
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
36
324
1.13
0.23
2.8
2.6
ug/l
0.7
0.7
0.03
28
181
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
39
1.29
0.23
2.2
1.8
%
13.8
13.2
—
5
39
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.2
—
—
—
0
0
(4211845)
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
10
0.00
0.21
0.0
2.8
—
4.2
—
0
10
(3044242) Glucose [Moles/volume] in Arterial blood
0
12
0.00
0.21
0.0
7.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
46
423
1.10
0.21
3.1
3.8
%
19.8
22.9
0.58
20
157
(3011288) Drugs identified in Urine by Screen method
9
112
0.80
0.20
1.8
3.3
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
14
0.00
0.20
0.0
1.1
—
5.8
—
0
14
(1001926) Buprenorphine [Presence] in Urine by Screen method
11
133
0.82
0.20
1.4
2.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
52
1.16
0.19
2.5
1.8
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
5
66
0.75
0.17
1.2
1.1
u/ml
0.6
1.4
—
5
24
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
8
69
1.16
0.16
1.3
1.8
pmol/l
213.4
243.0
—
8
62
(40768793) Breast Pathology biopsy report
8
69
1.16
0.16
1.1
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
71
674
1.07
0.16
1.5
1.7
mmol/l
1.3
1.4
0.51
66
582
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
13
151
0.85
0.16
1.1
1.0
—
—
—
0
0
(3019225) pH of Specimen
21
188
1.13
0.15
7.3
4.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
13
148
0.87
0.13
1.2
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
6
57
1.05
0.08
3.0
1.7
nmol/l
0.7
0.8
—
6
48
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
60
0.83
0.08
1.6
1.6
—
—
—
0
0
(4094501)
7
64
1.10
0.08
1.1
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
221
2232
0.96
0.08
5.6
5.0
mmol/mol
37.8
38.7
0.67
215
2110
(1002224) Polysomnography panel
16
147
1.09
0.07
1.1
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
8
78
1.03
0.07
1.5
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
7
81
0.86
0.07
1.6
2.9
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
8
93
0.86
0.07
1.4
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
10
91
1.10
0.04
4.5
3.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
12
122
0.98
0.00
1.5
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
14
141
0.99
0.00
4.9
2.2
—
—
—
0
0
(3013512) EKG study
60
596
1.01
0.00
4.6
3.3
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
7
0.00
0.00
0.0
6.9
—
—
—
0
0
(4133840)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.8
—
66.5
—
0
5
(3008401) Mugwort IgE Ab [Units/volume] in Serum
5
55
0.91
0.00
1.0
1.1
u/ml
0.2
0.9
—
5
20
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
5
56
0.89
0.00
1.8
1.8
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
5
0.00
0.00
0.0
3.0
—
83.8
—
0
5
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
5
0.00
0.00
0.0
1.0
—
3.3
—
0
5
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
7
0.00
0.00
0.0
3.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
58
0.86
0.00
1.2
1.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
6.5
—
0
6
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
6
59
1.02
0.00
1.0
1.0
u/ml
4.5
6.8
—
6
27
(3005033) Fetal Nuchal fold Thickness US
5
58
0.86
0.00
1.2
1.4
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
67
0.89
0.00
1.8
1.6
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint D3_KELA_IMMUDEF and mortality.

Females

Parameter HR [95% CI] p-value
D3_KELA_IMMUDEF 5.013 [3.21, 7.83] < 0.001
Birth year 0.998 [0.99, 1.01] 0.595

During the follow-up period (1.1.1998 — 31.12.2019), 53 out of 416 females with D3_KELA_IMMUDEF died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have D3_KELA_IMMUDEF.

N-year risk Females Males
1 0.44% No data
5 3.202% No data
10 7.618% No data
15 14.22% No data
20 23.763% No data

Relationships between endpoints

↥

Index endpoint: D3_KELA_IMMUDEF – Kela reimbursement Agammaglobulinemia (D80-84)

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data